Accelerated Return Bear Market Notes Linked TO S&P 500 Index (NBM) 시세

PlaceboJeffect you must be the new cheerleader for PWDY, and that is just fine, you can be positive that is a good thing in life to be. However, I have been riding the powerdyne train since its inception and if I want to vent, I have every right to do so. I know it's a small co.; put it talks the t

>

We have been told over and over again that the company PRs are the ONLY way to know the real "truth" about KBLB.

OK, well, let's take a look at that so-called "truth" from some of KBLB's PRs over the years:

-

Not directly but indirectly. Sr. Exec tells Son in Law ..... happens all the time

Today Kblb is on second place on BREAKOUT BOARDS on ihub again, guess why!?

The daily chart manipulation is more obvious than a blue sky by sunshine, the interested buyout companies are for sure heavily behind and trying everything to hold this company's pps down as long as possible b

https://stockcharts.com/h-sc/ui?s=icon&p=D&yr=0&mn=3&dy=0&id=p11960084343#google_vignette

IMHO we'll be just fine...!

imagizer.imageshack.com/v2/1600x1200q70/923/OV8dMi.jpg

let MONI's C-Suite executives circle back on a "100% ownership stake" in ShieldCom acquisition -

but only after Indexr's launch - when the time is right

als

nice AZRH https://youtu.be/lQu2qL8RD9A

nice AZRH https://youtu.be/lQu2qL8RD9A

nice AZRH https://youtu.be/lQu2qL8RD9A

Devon Orthopedic Implants revenue $3.4 million https://rocketreach.co/devon-orthopedic-implants-profile_b7ece26dc31bbc37

WMT
Walmart price target raised to $120 from $98 at Citi
Citi raised the firm's price target on Walmart to $120 from $98 and keeps a Buy rating on the shares. The firm expects the company's Q4 earnings to beat consensus estimates and guidance. Citi models reported net sales up 3.9%

Thanks Trader..that says that AZL is using Kochs DLE..not IBATS...I dont know if they are commercially tested already..Oh well, like to know where our first plant is now...whats up next? stay tuned as Iris Jancik stated..Lithium prices must go up as you said..but something is brewing here with IBAT.

Novartis agrees to acquire Anthos for up to $3.1B
Novartis (NVS) announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical company with abelacimab, a late-stage medicine in development for the prevent

I would highly recommand to all the so active daily naysayers to sell all their shares and let this board to facts from the company.

It is so boring to "read" this daily bs that is just due to put a bad picture on a fiberworld changing company.

Yesterday's pr just put

the PR for annual results mentioned release on February 13th. is it a must for them/alwyas after market?
or any suprise here?

You are correct yet again, King 👑 !!!!!!!!!!!!!

IB_ will be door dashing chicken wings and grabbing a 12 pack of Guinness Extra Stout .................

I believe the quarterly report will be ok, as long as nasrat has not diluted more shares but I do not expect a

Suction power reactivates for a limited time only special.)3.05 to 5.08 +'65% has to break $5.44 to test $6s again

phillips

https://www.wsj.com/finance/activist-elliott-ratchets-up-pressure-on-phillips-66-with-over-2-5-billion-stake-af2fc33c?mod=hp_lead_pos11

IBM
IBM initiated with an Outperform at Oppenheimer
Oppenheimer analyst Param Singh initiated coverage of IBM with an Outperform rating and $320 price target.

Can you tweak the sticky board so it looks a little less like the bulletin board in detention hall?

EU says Trump tariffs will trigger firm countermeasures

I won't say it either but we can all see it isn't done yet.  And it's nothing until it's done.  

I guess we will see how it plays out

Says the 🤡 that advised everyone to SELL right before 100,000% run. Yes, seems you are still here giving bad advice. Didn't learn a damn thing from that lesson, lmao.